Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like ADAS iiT Consortium earns National Instruments’ 2018 Technical Innovation Award February 13, 2018 Latest Production Tech: OMRON 2D Inspection Machine, Yokogawa IIoT Sensor & More January 8, 2019 Banks scrambling to get books in order as deadline for resolution of bad loans looms March 19, 2017